Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema

Inclusion Criteria:

• Diagnosis of AD/eczema as defined by Williams's criteria with clinical signs ofinfected AD/eczema on trunk and/or extremities such as fluid drainage, blisteredskin, white or yellow pus, severe itchiness and new burning sensation

• A minimum score of 1 for each of the signs in the m-EASI score in at least one ofthe pre-defined body areas (trunk and/or extremities)

• Subjects between 2 and 65 years of age

Exclusion Criteria:

• History of concurrent diseases that could interfere with trial assessments or pose asafety concern

• Subjects with other skin lesions, e.g. scarring, tattoos, or hyperpigmentation onthe treatment area that could interfere with assessments

• Clinical findings such as severe heart, liver, kidney and lung deficiency, whichwill be impacted by the trial procedures at the investigator's discretion

• Subjects who have received treatment with any non-marketed drug substance (i.e. anagent which has not yet been made available for clinical use following registration)within the last 4 weeks prior to randomisation at investigator's discretion

• Use of prohibited medication, i.e.

1. Systemic treatment with immunosuppressive or immunomodulating drugs(includingLeigongteng) or corticosteroids within 28 days prior to randomisation

2. Use of topical or systemic antibiotics and anti-histamines within 14 days priorto randomisation

3. Phototherapy (e.g. PUVA, UVA or UVB therapy) within 28 days prior torandomisation

4. Topical treatment with immunomodulators (e.g. pimecrolimus, tacrolimus) within 14 days prior to randomisation

5. Topical treatment with corticosteroids or any other topical treatment within 7days prior to randomisation

6. Use of any non-prescribed systemic or cutaneous medication within 7 days priorto randomisation

7. The use of analgesics at the discretion of the investigator is allowed beforeand during the trial